{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:30:52Z","timestamp":1794609052242,"version":"4.9.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Progestogens are steroid compounds that have the ability to induce secretory transformation in the endometrium and are utilized in menopausal hormone therapy to prevent endometrial hyperplasia and endometrial cancer. Progestogens can be derived from 21-carbon or 19-carbon steroid cytoskeletons and thus have different properties and metabolic effects beyond the progestational effects on the endometrium. This limited review will focus on the available progestogens utilized in combination hormone therapy including progesterone, medroxyprogesterone acetate, norethindrone, norethindrone acetate, levonorgestrel, and drospirenone. The impact of progestogens on a variety of target tissues including the endometrium, breast, cardiovascular system, brain, and bone, will be reviewed. Last, the current clinical regimens that can be utilized by clinicians will be discussed.<\/jats:p>","DOI":"10.1097\/grf.0000000000000657","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T04:18:43Z","timestamp":1633061923000},"page":"772-783","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["The Role of Progestogens in Menopausal Hormone Therapy"],"prefix":"10.1097","volume":"64","author":[{"given":"James H.","family":"Liu","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology"},{"name":"Reproductive Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0015-0282(16)56031-2","article-title":"The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone","volume":"60","author":"Simon","year":"1993","journal-title":"Fertil Steril"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(16)56935-0","article-title":"Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study","volume":"62","author":"Miles","year":"1994","journal-title":"Fertil Steril"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00042192-200512020-00019","article-title":"Percutaneous administration of progesterone: blood levels and endometrial protection","volume":"12","author":"Stanczyk","year":"2005","journal-title":"Menopause"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0010-7824(76)90099-8","article-title":"Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginally","volume":"14","author":"Victor","year":"1976","journal-title":"Contraception"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719110382922","article-title":"Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing?","volume":"18","author":"Mesiano","year":"2011","journal-title":"Reprod Sci"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yfrne.2008.01.001","article-title":"Characteristics of membrane progestin receptor \u03b1 (mPR\u03b1) and progesterone membrane receptor component I (PGMRC1) and their roles in mediating rapid progestin actions","volume":"29","author":"Thomas","year":"2008","journal-title":"Front Neuroendocrinol"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"275","year":"1996","journal-title":"JAMA"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/aje\/kwu146","article-title":"Risks of endometrial cancer associated with different replacement therapies in the E3N Cohort, 1992-2008","volume":"180","author":"Fournier","year":"2014","journal-title":"Am J Epidemiol"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/aje\/kwq300","article-title":"Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition","volume":"172","author":"Allen","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/aje\/kwaa210","article-title":"Randomized trial evaluation of the benefits and risks of menopausal hormone therapy among women 50-59 years of age","volume":"190","author":"Prentice","year":"2021","journal-title":"Am J Epidemiol"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3390\/cancers12082195","article-title":"Menopausal hormone therapy and risk of endometrial cancer: a systematic review","volume":"12","author":"Tempfer","year":"2020","journal-title":"Cancer (Basel)"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0015-0282(99)00162-4","article-title":"The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five year experience","volume":"72","author":"Suvanto-Luukkonen","year":"1999","journal-title":"Fertil Steril"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"R306","DOI":"10.1186\/bcr994","article-title":"Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during follicular and luteal phase of the menstrual cycle","volume":"7","author":"Navarreta","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00003","article-title":"Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen\/Progestin Interventions (PEPI) Investigators","volume":"130","author":"Greendale","year":"1999","journal-title":"Ann Intern Med"},{"key":"R20-20250512","first-page":"1159","article-title":"Menopausal hormone therapy and 20-year breast cancer mortality","volume":"294","author":"Beral","year":"2019","journal-title":"Lancet"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3892\/ijo.2014.2329","article-title":"Mechanisms underlying differential response to estrogen-induced apoptosis in long term estrogen-deprived breast cancer cells","volume":"44","author":"Sweeney","year":"2014","journal-title":"Int J Oncol"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fornier","year":"2005","journal-title":"Int J Cancer"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10549-014-2934-6","article-title":"Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort","volume":"145","author":"Fornier","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen\/progestin interventions (PEPI) trial","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N Engl J Med"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormonal therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"R30-20250512","first-page":"1465","article-title":"Hormone therapy for preventing cardiovascular disease in postmenopausal women","volume":"3","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1210\/en.2007-1592","article-title":"Progesterone biosynthesis and action in the developing neuron","volume":"149","author":"Tsutsui","year":"2008","journal-title":"Endocrinology"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1385\/ENDO:29:2:271","article-title":"Progesterone-induced neuroprotection","volume":"29","author":"Singh","year":"2006","journal-title":"Endocrine"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1210\/endo.143.1.8582","article-title":"Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate","volume":"143","author":"Nilsen","year":"2002","journal-title":"Endocrinology"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women\u2019s Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"e000369","DOI":"10.1161\/JAHA.113.000369","article-title":"Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women\u2019s Health Initiative Memory Study","volume":"2","author":"Haring","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R36-20250512","first-page":"789","article-title":"Prevention of bone mineral loss in postmenopausal women by norethisterone","volume":"66","author":"Abdalla","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0002-9343(94)90092-2","article-title":"Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances","volume":"96","author":"Prior","year":"1994","journal-title":"Am J Med"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ajog.2004.12.067","article-title":"The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial","volume":"192","author":"Liu","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198610093151504","article-title":"A simple method for determining the optimal dosage of progestin in post-menopausal women receiving estrogens","volume":"315","author":"Padwick","year":"1986","journal-title":"N Engl J Med"},{"key":"R41-20250512","first-page":"693","article-title":"Cyclic hormone replacement therapy using quarterly progestin","volume":"83","author":"Ettinger","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R42-20250512","first-page":"205","article-title":"Low-dosage esterified estrogen opposed by progestin at 6 month intervals","volume":"98","author":"Ettinger","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.gme.0000185119.74706.7b","article-title":"Endometrial safety and bleeding pattern during a five-year treatment with long-cycle hormone therapy","volume":"12","author":"Odmark","year":"2005","journal-title":"Menopause"},{"key":"R44-20250512","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/AOG.0b013e3181bea950","article-title":"Endometrial cancer in postmenopausal women using estradiol-progestin therapy","volume":"114","author":"Jaakkola","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5122(99)00076-6","article-title":"Estrogens with interrupted progestin HRT: a review of experimental and clinical studies","volume":"34","author":"Casper","year":"2000","journal-title":"Maturitas"},{"key":"R46-20250512","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/GME.0000000000001326","article-title":"The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?","volume":"26","author":"Miller","year":"2019","journal-title":"Menopause"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:11:09Z","timestamp":1747062669000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000657","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,29]]}}}